In brief

England’s cancer services are in danger of deteriorating: All clinical commissioning groups should have a member who leads on cancer, experts are urging in the PACE (Patient Access to Cancer care Excellence) UK report.1 The authors warn that progress in cancer care is now in danger of reversing because of loss of experienced staff in the recent NHS changes. They recommend collaboration and the sharing of best practice, building cancer expertise in the new commissioning bodies, and clarifying the long term pricing and reimbursement schemes for new drugs.

NICE advises more use of durable hips: The National Institute for Health …